# A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-fe-iii-porphyrin-oxaliplatin-iv-nanoplatform-for-enhanced-ferroptosis-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xiaochun Hu,Ruihao Li,Wenjing Wu,Kang Fang,Zhounan Zhu,Yixuan Wang,Lulu Zhou,Mengyao Chen,Chunyan Dong,Shuo Shi |
| Citations | 77 |
| DOI | 10.1016/j.jconrel.2022.06.019 |
| Fields | Engineering,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4283156727 |
| PMID | 35716884 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Lulu Zhou](https://scholariq.org/researchers/lulu-zhou/)

## Paper primary topic

- [Nanoplatforms for cancer theranostics](https://scholariq.org/topics/nanoplatforms-for-cancer-theranostics/)

## Paper topics

- [Nanoplatforms for cancer theranostics](https://scholariq.org/topics/nanoplatforms-for-cancer-theranostics/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.